chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue
Clinical narrative: developed Covid infection after the 1st dose of Moderna Vaccine/Contracted Covid; Doctor advised to wait for 3 months to get second dose/Over 35 days from 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (developed Covid infection after the 1st dose of Moderna Vaccine/Contracted Covid) and PRODUCT DOSE OMISSION ISSUE (Doctor advised to wait for 3 months to get second dose/Over 35 days from 1st dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (developed Covid infection after the 1st dose of Moderna Vaccine/Contracted Covid) and PRODUCT DOSE OMISSION ISSUE (Doctor advised to wait for 3 months to get second dose/Over 35 days from 1st dose). At the time of the report, COVID-19 (developed Covid infection after the 1st dose of Moderna Vaccine/Contracted Covid) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Doctor advised to wait for 3 months to get second dose/Over 35 days from 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided by reporter. No treatment information provided by reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow up received included new event, first dose date updated, event onset date updated.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Malaise, Nausea
Clinical narrative: diarrhea; loss of appetite; feeling sick; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), DECREASED APPETITE (loss of appetite), MALAISE (feeling sick) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced DIARRHOEA (diarrhea), DECREASED APPETITE (loss of appetite), MALAISE (feeling sick) and NAUSEA (nausea). At the time of the report, DIARRHOEA (diarrhea), DECREASED APPETITE (loss of appetite), MALAISE (feeling sick) and NAUSEA (nausea) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Vomiting
Clinical narrative: nausea; vomiting; severe headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), VOMITING (vomiting), HEADACHE (severe headache) and CHILLS (chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No medical history information informed.  Concomitant products included ATORVASTATIN, HYDROXYCHLOROQUINE, LOSARTAN, FLUOXETINE, DICYCLOMINE HCL, DILTIAZEM, CEFUROXIME, CICLOSPORIN (RESTASIS), DENOSUMAB (PROLIA), ACETYLSALICYLIC ACID (BABY ASPIRIN), CYANOCOBALAMIN, FOLIC ACID, IRON POLYSACCHARIDE COMPLEX (POLY-IRON FORTE), PANTOPRAZOLE and VITAMINS NOS for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting), HEADACHE (severe headache) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NAUSEA (nausea), VOMITING (vomiting), HEADACHE (severe headache) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-067293 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067293:
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore Arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore Arm). At the time of the report, VACCINATION SITE PAIN (Sore Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-067149 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067149:crosslinked with husband case
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Rash around injection site after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash around injection site after 1st dose) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Rash around injection site after 1st dose). At the time of the report, VACCINATION SITE RASH (Rash around injection site after 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: UTI (urinary tract infection); This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI (urinary tract infection)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (UTI (urinary tract infection)). At the time of the report, URINARY TRACT INFECTION (UTI (urinary tract infection)) outcome was unknown.            No concomitant medications were provided. Treatment medications were not provided. Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Palpitations, Rash, Rash pruritic, Vaccination site rash
Clinical narrative: Heart palpitations; very unusual vaginal bleeding (described as a menstrual period) that lasted 3 wks; an itchy hot rash; rash on right knee; rash on arm belowinjection site / size of softball /  3-4 inches in diameter; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart palpitations), VAGINAL HAEMORRHAGE (very unusual vaginal bleeding (described as a menstrual period) that lasted 3 wks), RASH PRURITIC (an itchy hot rash), RASH (rash on right knee) and VACCINATION SITE RASH (rash on arm belowinjection site / size of softball /  3-4 inches in diameter) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Postmenopausal syndrome, Chronic kidney disease stage 3, Drug allergy (Quinine), Drug allergy (Levaquin), Allergy to antibiotic (Ciprofloxacin), Shellfish allergy and Allergy (Artificial sweeteners).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PALPITATIONS (Heart palpitations), VAGINAL HAEMORRHAGE (very unusual vaginal bleeding (described as a menstrual period) that lasted 3 wks), RASH PRURITIC (an itchy hot rash), RASH (rash on right knee), VACCINATION SITE RASH (rash on arm belowinjection site / size of softball /  3-4 inches in diameter) and HEADACHE (Headache). At the time of the report, PALPITATIONS (Heart palpitations), VAGINAL HAEMORRHAGE (very unusual vaginal bleeding (described as a menstrual period) that lasted 3 wks), RASH PRURITIC (an itchy hot rash), RASH (rash on right knee), VACCINATION SITE RASH (rash on arm belowinjection site / size of softball /  3-4 inches in diameter) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. No treatment information provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: Heart palpitations; very unusual vaginal bleeding (described as a menstrual period) that lasted 3 wks; an itchy hot rash; rash on right knee; rash on arm belowinjection site / size of softball /  3-4 inches in diameter; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart palpitations), VAGINAL HAEMORRHAGE (very unusual vaginal bleeding (described as a menstrual period) that lasted 3 wks), RASH PRURITIC (an itchy hot rash), RASH (rash on right knee) and VACCINATION SITE RASH (rash on arm belowinjection site / size of softball /  3-4 inches in diameter) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Postmenopausal syndrome, Chronic kidney disease stage 3, Drug allergy (Quinine), Drug allergy (Levaquin), Allergy to antibiotic (Ciprofloxacin), Shellfish allergy and Allergy (Artificial sweeteners).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PALPITATIONS (Heart palpitations), VAGINAL HAEMORRHAGE (very unusual vaginal bleeding (described as a menstrual period) that lasted 3 wks), RASH PRURITIC (an itchy hot rash), RASH (rash on right knee), VACCINATION SITE RASH (rash on arm belowinjection site / size of softball /  3-4 inches in diameter) and HEADACHE (Headache). At the time of the report, PALPITATIONS (Heart palpitations), VAGINAL HAEMORRHAGE (very unusual vaginal bleeding (described as a menstrual period) that lasted 3 wks), RASH PRURITIC (an itchy hot rash), RASH (rash on right knee), VACCINATION SITE RASH (rash on arm belowinjection site / size of softball /  3-4 inches in diameter) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. No treatment information provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nasal congestion
Clinical narrative: Stuffy nose; headache; Sore arm on Thursday; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Stuffy nose), MYALGIA (Sore arm on Thursday) and HEADACHE (headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No medical history information provided.  Concomitant products included PAROXETINE for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced MYALGIA (Sore arm on Thursday). On 02-Apr-2021, the patient experienced NASAL CONGESTION (Stuffy nose) and HEADACHE (headache). At the time of the report, NASAL CONGESTION (Stuffy nose), MYALGIA (Sore arm on Thursday) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaginal haemorrhage
Clinical narrative: spotting; headaches; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (spotting) and HEADACHE (headaches) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced VAGINAL HAEMORRHAGE (spotting) and HEADACHE (headaches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, VAGINAL HAEMORRHAGE (spotting) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included paracetamol and ibuprofen.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pain, Pain in extremity
Clinical narrative: soreness in my arm; body aches; fever of 101; chills; headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in my arm), PAIN (body aches), PYREXIA (fever of 101), CHILLS (chills) and HEADACHE (headaches) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness in my arm), PAIN (body aches), PYREXIA (fever of 101), CHILLS (chills) and HEADACHE (headaches). At the time of the report, PAIN IN EXTREMITY (soreness in my arm), PAIN (body aches), PYREXIA (fever of 101), CHILLS (chills) and HEADACHE (headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Apr-2021, Body temperature: 101 (High) 101 fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The consumer tried to control her temperature with cold cloths, ibuprofen, and has been drinking water and Gatorade.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: soreness in my arm; body aches; fever of 101; chills; headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in my arm), PAIN (body aches), PYREXIA (fever of 101), CHILLS (chills) and HEADACHE (headaches) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness in my arm), PAIN (body aches), PYREXIA (fever of 101), CHILLS (chills) and HEADACHE (headaches). At the time of the report, PAIN IN EXTREMITY (soreness in my arm), PAIN (body aches), PYREXIA (fever of 101), CHILLS (chills) and HEADACHE (headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Apr-2021, Body temperature: 101 (High) 101 fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The consumer tried to control her temperature with cold cloths, ibuprofen, and has been drinking water and Gatorade.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeding disorder, Gait inability, Hyperhidrosis, Nausea
Clinical narrative: pain; sweat; could not walk; could not eat; chills; nausea; rash was itchy; rash on her back; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), HYPERHIDROSIS (sweat), GAIT INABILITY (could not walk), FEEDING DISORDER (could not eat) and RASH PRURITIC (rash was itchy) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced RASH PRURITIC (rash was itchy) and RASH (rash on her back). On an unknown date, the patient experienced PAIN (pain), HYPERHIDROSIS (sweat), GAIT INABILITY (could not walk), FEEDING DISORDER (could not eat), CHILLS (chills) and NAUSEA (nausea). On 20-Mar-2021, RASH PRURITIC (rash was itchy) and RASH (rash on her back) had resolved. On 04-Apr-2021, PAIN (pain), HYPERHIDROSIS (sweat), GAIT INABILITY (could not walk), FEEDING DISORDER (could not eat), CHILLS (chills) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash, Rash pruritic
Clinical narrative: pain; sweat; could not walk; could not eat; chills; nausea; rash was itchy; rash on her back; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), HYPERHIDROSIS (sweat), GAIT INABILITY (could not walk), FEEDING DISORDER (could not eat) and RASH PRURITIC (rash was itchy) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced RASH PRURITIC (rash was itchy) and RASH (rash on her back). On an unknown date, the patient experienced PAIN (pain), HYPERHIDROSIS (sweat), GAIT INABILITY (could not walk), FEEDING DISORDER (could not eat), CHILLS (chills) and NAUSEA (nausea). On 20-Mar-2021, RASH PRURITIC (rash was itchy) and RASH (rash on her back) had resolved. On 04-Apr-2021, PAIN (pain), HYPERHIDROSIS (sweat), GAIT INABILITY (could not walk), FEEDING DISORDER (could not eat), CHILLS (chills) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: still experiencing arm soreness,; swollen; red; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (still experiencing arm soreness,), PERIPHERAL SWELLING (swollen) and ERYTHEMA (red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PAIN IN EXTREMITY (still experiencing arm soreness,), PERIPHERAL SWELLING (swollen) and ERYTHEMA (red). At the time of the report, PAIN IN EXTREMITY (still experiencing arm soreness,), PERIPHERAL SWELLING (swollen) and ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-069203, MOD21-069239 (E2B Linked Report).; Sender's Comments:  MOD21-069203: MOD21-069239:
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Product administration error, Underdose
Clinical narrative: liquid that came out...after their first dose was a lot; liquid that came out...after their first dose was a lot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION ERROR (liquid that came out...after their first dose was a lot) and UNDERDOSE (liquid that came out...after their first dose was a lot) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN for Diabetes.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (liquid that came out...after their first dose was a lot) and UNDERDOSE (liquid that came out...after their first dose was a lot). On 09-Feb-2021, PRODUCT ADMINISTRATION ERROR (liquid that came out..after their first dose was a lot) and UNDERDOSE (liquid that came out..after their first dose was a lot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Action taken with mRNA-1273 in response to events was not applicable as patient already took the second dose. No treatment information was provided.  This report refers to a case of Product administration error and underdose for mRNA-1273, lot # 026A21A  with no associated AEs.; Sender's Comments: This report refers to a case of Product administration error and underdose for mRNA-1273, lot # 026A21A  with no associated AEs.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Headache, Pain, Paraesthesia
Clinical narrative: headache; soreness; discomfort; tingling; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness), DISCOMFORT (discomfort), PARAESTHESIA (tingling) and HEADACHE (headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B or 03AZ1B) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PAIN (soreness), DISCOMFORT (discomfort), PARAESTHESIA (tingling) and HEADACHE (headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN (soreness), DISCOMFORT (discomfort), PARAESTHESIA (tingling) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment include some exercise (walk) which helped her reducing symptoms.
Sex: F
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: Planning for second dose of vaccine past 42 days from  the first; This spontaneous case was reported by a pharmacist and describes the occurrence of OFF LABEL USE (Planning for second dose of vaccine past 42 days from  the first) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Back surgery.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced OFF LABEL USE (Planning for second dose of vaccine past 42 days from  the first). At the time of the report, OFF LABEL USE (Planning for second dose of vaccine past 42 days from  the first) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Because of the back surgery, the health care provider of the patient did not recommend second dose on time.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for Covid; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Tested positive for Covid) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced COVID-19 (Tested positive for Covid). At the time of the report, COVID-19 (Tested positive for Covid) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, SARS-CoV-2 test: postive (Positive) Tested positive for Covid.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: hot to touch; 7-8 days later, arm itching; bright red circle; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (7-8 days later, arm itching) and VACCINATION SITE INDURATION (bright red circle) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (7-8 days later, arm itching) and VACCINATION SITE INDURATION (bright red circle). On 27-Mar-2021, VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (7-8 days later, arm itching) and VACCINATION SITE INDURATION (bright red circle) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       .
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Swelling, Vaccination site pain
Clinical narrative: Swelling behind knee; Arm is sore at the site of injection; Arm is sore at the site of injection; Fever; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of VACCINATION SITE PAIN (Arm is sore at the site of injection), SWELLING (Swelling behind knee), PYREXIA (Fever) and the second episode of VACCINATION SITE PAIN (Arm is sore at the site of injection) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On 02-Mar-2021, the patient experienced the first episode of VACCINATION SITE PAIN (Arm is sore at the site of injection) and PYREXIA (Fever). On 31-Mar-2021, the patient experienced SWELLING (Swelling behind knee) and the second episode of VACCINATION SITE PAIN (Arm is sore at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SWELLING (Swelling behind knee), PYREXIA (Fever) and the last episode of VACCINATION SITE PAIN (Arm is sore at the site of injection) outcome was unknown.            This case was linked to MOD-2021-065268 (Patient Link).
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Nasal congestion, Oropharyngeal pain
Clinical narrative: sore throat; nasal congestion; Tested Positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (nasal congestion) and COVID-19 (Tested Positive for COVID-19) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concomitant products included CELECOXIB (CELEXA [CELECOXIB]), ATORVASTATIN CALCIUM (LIPITOR) and VITAMINS NOS (DAILY VITAMINS) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced COVID-19 (Tested Positive for COVID-19). On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat) and NASAL CONGESTION (nasal congestion). At the time of the report, OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (nasal congestion) and COVID-19 (Tested Positive for COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: High temperature; Swelling on injection site; Redness on injection site; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (High temperature), VACCINATION SITE SWELLING (Swelling on injection site) and VACCINATION SITE ERYTHEMA (Redness on injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (High temperature), VACCINATION SITE SWELLING (Swelling on injection site) and VACCINATION SITE ERYTHEMA (Redness on injection site). At the time of the report, PYREXIA (High temperature), VACCINATION SITE SWELLING (Swelling on injection site) and VACCINATION SITE ERYTHEMA (Redness on injection site) outcome was unknown.            No concomitant medications reported by investigator  No treatment medications provided by the reporter.     This case was linked to MOD21-069742.; Sender's Comments:  MOD21-069742:child case crosslinked
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: rash on arm at injection site and elbow; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash on arm at injection site and elbow) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021A21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INJECTION SITE RASH (rash on arm at injection site and elbow). At the time of the report, INJECTION SITE RASH (rash on arm at injection site and elbow) outcome was unknown. Not Provided
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain at injection site radiated and is over the left chest area, spreading over; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (pain at injection site radiated and is over the left chest area, spreading over) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 027A21A) for COVID-19 vaccination.  No Medical History information was reported.  On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site radiated and is over the left chest area, spreading over). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (pain at injection site radiated and is over the left chest area, spreading over) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Vomiting
Clinical narrative: Next Day, she couldn't keep her eyes open at work as she felt tired; Ever since the day of receiving 1st dose, she feels fatigued / She is exhausted; She lost her appetite; Within 1/2 hour of getting vaccine, she vomited once; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (She lost her appetite), VOMITING (Within 1/2 hour of getting vaccine, she vomited once), FATIGUE (Next Day, she couldn't keep her eyes open at work as she felt tired) and FATIGUE (Ever since the day of receiving 1st dose, she feels fatigued / She is exhausted) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 29-Mar-2021, the patient experienced DECREASED APPETITE (She lost her appetite), VOMITING (Within 1/2 hour of getting vaccine, she vomited once) and FATIGUE (Ever since the day of receiving 1st dose, she feels fatigued / She is exhausted). On 30-Mar-2021, the patient experienced FATIGUE (Next Day, she couldn't keep her eyes open at work as she felt tired). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (She lost her appetite), VOMITING (Within 1/2 hour of getting vaccine, she vomited once), FATIGUE (Next Day, she couldn't keep her eyes open at work as she felt tired) and FATIGUE (Ever since the day of receiving 1st dose, she feels fatigued / She is exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient under the age of 18 received the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under the age of 18 received the vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under the age of 18 received the vaccine). On 05-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under the age of 18 received the vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. No treatment information was provided.   Reporter did not allow further contact
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (sore arm) and fatigue in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19  vaccine) for COVID-19 immunization. No medical history reported. On Mar 22, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 23, 2021, patient experienced pain in extremity (sore arm) and fatigue. At the time of the report, pain in extremity (sore arm) and fatigue outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, Headache
Clinical narrative: Elevated blood glucose; Pounding headache; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Elevated blood glucose) and HEADACHE (Pounding headache) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 03-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced BLOOD GLUCOSE INCREASED (Elevated blood glucose) and HEADACHE (Pounding headache). The patient was treated with NAPROXEN SODIUM (ALEVE) for Pounding in head, at an unspecified dose and frequency. At the time of the report, BLOOD GLUCOSE INCREASED (Elevated blood glucose) and HEADACHE (Pounding headache) outcome was unknown.            No concomitant medications were reported.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching all over the body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over the body) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, the patient experienced PRURITUS (Itching all over the body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching all over the body) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-May-2021: No specific follow-up information recorded.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Rash on the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on the arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Migraine and Allergy.    On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced VACCINATION SITE RASH (Rash on the arm). At the time of the report, VACCINATION SITE RASH (Rash on the arm) outcome was unknown. Not Provided          No concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Headache, Pain
Clinical narrative: Pain on right side of chest, more intense when breathing in; Headache; Intense pain on whole body; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Intense pain on whole body), CHEST PAIN (Pain on right side of chest, more intense when breathing in) and HEADACHE (Headache) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006BZ1A and 030AZ1A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced PAIN (Intense pain on whole body) and HEADACHE (Headache). On 05-Apr-2021, the patient experienced CHEST PAIN (Pain on right side of chest, more intense when breathing in). The patient was treated with IBUPROFEN at a dose of 600 mg. At the time of the report, PAIN (Intense pain on whole body), CHEST PAIN (Pain on right side of chest, more intense when breathing in) and HEADACHE (Headache) was resolving. Not Provided
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Nasal congestion, Nasopharyngitis
Clinical narrative: Second Shot is scheduled for 06APR2021; Head Cold; Congested; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Shot is scheduled for 06APR2021), NASOPHARYNGITIS (Head Cold) and NASAL CONGESTION (Congested) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced NASOPHARYNGITIS (Head Cold) and NASAL CONGESTION (Congested). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Shot is scheduled for 06APR2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Shot is scheduled for 06APR2021), NASOPHARYNGITIS (Head Cold) and NASAL CONGESTION (Congested) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). At the time of the report, PAIN IN EXTREMITY (Sore Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Blood potassium decreased, Chills, Electrocardiogram, Heart rate increased, Nausea
Clinical narrative: Rapid heart beats; Arm ache; Low potassium; Fever; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Rapid heart beats), PAIN IN EXTREMITY (Arm ache), BLOOD POTASSIUM DECREASED (Low potassium), PYREXIA (Fever) and CHILLS (Chills) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high. Concomitant products included BUSPIRONE for Allergy NOS, OMEPRAZOLE for Stomach discomfort.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced HEART RATE INCREASED (Rapid heart beats), PAIN IN EXTREMITY (Arm ache), BLOOD POTASSIUM DECREASED (Low potassium), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). On 08-Mar-2021, PAIN IN EXTREMITY (Arm ache) had resolved. At the time of the report, HEART RATE INCREASED (Rapid heart beats), BLOOD POTASSIUM DECREASED (Low potassium), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Electrocardiogram: low potassium level Potassium level was little low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.   Reporter did not allow further contact
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Rapid heart beats; Arm ache; Low potassium; Fever; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Rapid heart beats), PAIN IN EXTREMITY (Arm ache), BLOOD POTASSIUM DECREASED (Low potassium), PYREXIA (Fever) and CHILLS (Chills) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high. Concomitant products included BUSPIRONE for Allergy NOS, OMEPRAZOLE for Stomach discomfort.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced HEART RATE INCREASED (Rapid heart beats), PAIN IN EXTREMITY (Arm ache), BLOOD POTASSIUM DECREASED (Low potassium), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). On 08-Mar-2021, PAIN IN EXTREMITY (Arm ache) had resolved. At the time of the report, HEART RATE INCREASED (Rapid heart beats), BLOOD POTASSIUM DECREASED (Low potassium), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Electrocardiogram: low potassium level Potassium level was little low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.   Reporter did not allow further contact
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling jittery
Clinical narrative: Light headed / Dizzy; Jittery; Mild fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headed / Dizzy), FEELING JITTERY (Jittery) and FATIGUE (Mild fatigue) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Light headed / Dizzy), FEELING JITTERY (Jittery) and FATIGUE (Mild fatigue). At the time of the report, DIZZINESS (Light headed / Dizzy), FEELING JITTERY (Jittery) and FATIGUE (Mild fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact